JM, R., I, C., A, M., I, V., A, S., N, B., . . . J, M. (2022). NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers, 14(20), . https://doi.org/10.3390/cancers14205169
Chicago Style (17th ed.) CitationJM, Rosa-Rosa, et al. "NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial." Cancers 14, no. 20 (2022). https://doi.org/10.3390/cancers14205169.
MLA (9th ed.) CitationJM, Rosa-Rosa, et al. "NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial." Cancers, vol. 14, no. 20, 2022, https://doi.org/10.3390/cancers14205169.
Warning: These citations may not always be 100% accurate.